Publication - Abstract
Dec 21, 2017
Journal of Infectious Diseases
M. Meyer, E. Huang, O. Yuzhakov, P. Ramanathan, G. Ciaramella and A. Bukreyev
Most current Ebola virus (EBOV) vaccine candidates are based on viral vectors, some of which cause side effects or require complex manufacturing. Modified mRNA vaccines are easily produced, safe, and are highly immunogenic. We developed 2 mRNA vaccines based on the EBOV envelope ...
Read More
Publication - Abstract
Mar 23, 2021
ACS Nano
F. Sebastiani, M.Y. Arteta, M. Lerche, L. Porcar, M. Cárdenas, et. al.
Emerging therapeutic treatments based on the production of proteins by delivering mRNA have become increasingly important in recent times. While lipid nanoparticles (LNPs) are approved vehicles for small interfering RNA delivery, there are still challenges to use this formulation...
Read More